Clinical Trial Results

Showing: All studies [change]
Condition: Hypertension Location: Washington 25 trials found
New Search
Filter
Trial Phase
Study Type
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
N/AOBSERVATIONAL Los Angeles, California +4 more
RECRUITING
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
NAINTERVENTIONAL Washington D.C., District of Columbia +2 more
RECRUITING
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NAINTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
PHASE3INTERVENTIONAL Fairhope, Alabama +4 more
RECRUITING
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
PHASE4INTERVENTIONAL Baltimore, Maryland +3 more
RECRUITING
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Spironolactone for Pulmonary Arterial Hypertension
PHASE2INTERVENTIONAL Bethesda, Maryland
RECRUITING
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Natural History of Noncirrhotic Portal Hypertension
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Diabetes and Heart Disease Risk in Blacks
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Study of Intravenous ZMA001 in Healthy Subjects
PHASE1INTERVENTIONAL Bethesda, Maryland
RECRUITING
Childhood-Onset Essential Hypertension Natural History Study
N/AOBSERVATIONAL Bethesda, Maryland
RECRUITING
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
PHASE3INTERVENTIONAL Bethesda, Maryland
RECRUITING
Pulmonary Hypertension Association Registry
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
PHASE3INTERVENTIONAL Fresno, California +4 more
RECRUITING
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
PHASE4INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
PHASE2INTERVENTIONAL Foley, Alabama +4 more
RECRUITING
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
PHASE3INTERVENTIONAL Vienna, Virginia
RECRUITING
Filter Trials
Trial Phase
Study Type